Board Advisory & Search Services

Why Governance Now Matters

Healthcare enterprises, whether publicly traded, mutual, not-for-profit, or integrated payer-provider systems, are operating under sustained economic and regulatory pressure.

Margin compression.
Pharmacy volatility.
Capital discipline.
Regulatory scrutiny.
AI governance risk.
C-Suite succession exposure.

Employee burnout & turnover.

In this environment, board composition is not ceremonial.

It is an enterprise risk variable.

Organizations do not outperform their governance design.

When boards are oversized, misaligned in capability, overly deferential, or structurally unclear about their role, performance deteriorates predictably, regardless of mission or ownership model.

Across health plans, integrated systems, and risk-bearing healthcare organizations, the same governance patterns surface repeatedly:

• Board composition that reflects history rather than enterprise capability. 
• Former executives whose continued influence constrains decisive authority.
• Loyalty or relationship-based director selection.
• Oversized boards following transactions.
• Consensus cultures that suppress constructive challenge.
• Performative self-assessment processes.
• Succession planning treated as episodic rather than continuous.
• Information flow filtered through management layers.
• Blurred governance–management boundaries.
• No credible mechanism for addressing underperforming directors.
   

These are not personality flaws.

They are structural design issues.

Left unaddressed, they compound.

A structured evaluation of:

• Board composition versus enterprise complexity.
• Director capability relative to regulatory, capital, and operational exposure.
• Committee structure alignment.
• CEO and C-suite succession oversight.
• Information flow and early risk detection.
• Cultural norms affecting candor and challenge.
• Governance–management boundary clarity.
   

The objective is not critique.

It is alignment.

Where gaps exist, MES supports:

• Independent director recruitment.
• Audit and risk committee strengthening.
• Technology and AI oversight capability.
• Government program expertise.
• Capital allocation and actuarial fluency.
• CEO succession and compensation oversight.
   

The objective is capability aligned to enterprise risk, not optics.

Where structural misalignment exists, we work directly with:

• CEOs 
• Board Chairs
• Governance and Nominating Committees

to realign expectations, accountability norms, and oversight clarity.

Governance reform is rarely technical.

It is adaptive.

It requires deliberate leadership at the top.

Steve McGovern has operated inside the healthcare leadership ecosystem since 2003.

Through decades of retained executive search across risk-bearing healthcare enterprises, MES maintains continuous dialogue with senior leaders navigating:

• Executive turnover. 
• Succession instability.
• Margin recalibration.
• Governance friction.
• Strategic misalignment.
• Capital sensitivity.
   

We see where governance strengthens enterprise performance.

And where it quietly constrains it.

That cross-enterprise perspective informs every board engagement.

Every assignment is founder-led.

No delegation.

Direct accountability from diagnostic through recruitment.

Board Advisory is most appropriate when:

• Performance instability persists despite strategic clarity. 
• CEO authority feels structurally constrained.
• Board size or composition reflects legacy structure rather than current complexity.
• Succession exposure is material.
• Governance culture suppresses constructive challenge.
• A transaction creates structural leverage for reset.
   

• Project-based or retained engagement
• Board Chair and/or CEO mandate
• Confidential and limited in scope

Governance reform requires discretion and candor.

To initiate a private discussion:

Steve McGovern
President & CEO
McGovern Executive Search
703-525-0508
steve@mcgovernexecutivesearch.com